Clarus Sees Third Investor Amass Shares
The company revealed in a statement that investment firm, Parallax Volatility Advisers had acquired more than 5% of its outstanding shares, above the threshold that would trigger its shareholder rights agreement without approval of the board. CLAR’s poison pill, which its board put in place is 2008, provides for a preferred stock dividend that—if triggered—would dilute ... Log in to view full article.
